Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Quercetin and Saccharomyces Boulardii are closely matched across evidence, studies, and safety.
Verdict
Likely helps
13 of 14 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Quercetin and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
500-1000mg
With meals containing fat, Split into 2 doses
Quercetin phytosome (improved absorption)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
2-4 weeks
2-4 weeks
4-8 weeks
During use
1-3 days
1-2 weeks
Quercetin as a therapeutic agent for skin problems: a systematic review and meta-analysis on antioxidant effects, oxidative stress, inflammation, wound healing, hyperpigmentation, aging, and skin cancer
Naunyn-Schmiedeberg's archives of pharmacology (2025) · Meta analysis · n=1398
Furthermore, quercetin significantly inhibited tyrosinase activity (Z-score, 1.95), resulting in a significantly reduced melanin content (Z-score, 2.56).
Efficacy and safety of dietary polyphenol supplements for COPD: a systematic review and meta-analysis
Frontiers in immunology (2025) · Meta analysis · n=894
This systematic review confirms that the efficacy of dietary polyphenols is significantly composition-specific.
Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis
PloS one (2024) · Meta analysis · n=3650
The rankings of safety and efficacy of the 12 antioxidants vary.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Meta-analysis of 896 subjects showed modest reductions in systolic (-3.09 mmHg) and diastolic (-2.86 mmHg) BP. Effect size is small and bioavailability varies significantly by form.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Both Quercetin and Saccharomyces Boulardii are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Saccharomyces Boulardii has a higher relevance score (90 vs 70).
No known interactions between Quercetin and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.